Switch to:
More From Other Websites
Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference Sep 22 2014
Arena Pharmaceuticals, Inc. (ARNA) Jumps: Stock Rises 9.5% Sep 19 2014
Doc Offers Glimpse Into Arena Pharma Weight-Loss Combination Therapy Sep 16 2014
[video] Orexigen drops in spite of FDA approval Sep 11 2014
U.S. FDA panel: Novo Nordisk's liraglutide safe/effective for obesity Sep 11 2014
Orexigen's Obesity Pill is Approved and Stock Falls. Don't be Surprised Sep 11 2014
Pharmalot, Pharmalittle: We're Reading About Orexigen, Allergan and Lots More!! Sep 11 2014
Lorcaserin HCl Data to be Presented at the American Society of Bariatric Physicians' 64th Annual... Sep 10 2014
FDA staff: Novo Nordisk drug liraglutide effective for obesity Sep 09 2014
Arena Pharmaceuticals' APD811 Gets Orphan Drug Status Sep 03 2014
Arena Pharmaceuticals' APD811 Granted Orphan Drug Status for Pulmonary Arterial Hypertension Sep 02 2014
[video] Obesity treatment sales fall short Aug 18 2014
ARENA PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report Aug 06 2014
Arena Pharmaceuticals Falls on Wider-than-Expected Q2 Loss Aug 04 2014
ARENA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 01 2014
Q2 2014 Arena Pharmaceuticals Earnings Release - After Market Close Aug 01 2014
Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results Aug 01 2014
Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3... Jul 30 2014
Eisai and Arena Pharmaceuticals Announce BELVIQ® (lorcaserin HCl) CIV Nominated a Second Time for... Jul 29 2014

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial